Latest filing published 17 Apr 2020 for Avalo Therapeutics, Inc., €14k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -38.9%Entry US$12,672.00 · Close at T+365 US$7,747.20
- -54.8%Entry US$15,552.00 · Close at T+365 US$7,027.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Pericles Calias: trading record in brief
Pericles Calias appears in our data through filings on Avalo Therapeutics, Inc. shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 24 May 2019 to 10 December 2019.
Every open-market trade on record is a purchase: 2 purchases worth €19k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants.
The record was last updated on 17 April 2020 with a share grant (€14k) in Avalo Therapeutics, Inc. The clock since the last published purchase (11 December 2019) now reads 2,525 days. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Pericles Calias
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,246 shares@ US$4.9065.4% of flowCommon StockSEC:0001578563-20-000019:0
- 2,913 shares@ US$2.8522.6% of flowCommon StockSEC:0001578563-19-000037:0Canonical exit: 9 Mar 2020 (T+90)
- 4,549 shares@ US$2.8534.6% of flowCommon StockSEC:0001578563-19-000020:0Canonical exit: 8 Sept 2019 (T+90)
- 45,000 shares0Common StockSEC:0001578563-19-000018:0
4 of 4 declarations
